Improving quality of life through innovative cellular therapies

Regeneus is excited to announce that over 450 patients have now been commercially treated with our HiQCell® stem cell therapy.

These patients are captured within our Patient Joint Registry which allows us to continue to capture long-term data so that we can learn more of the treatment effects of HiQCell.

More about HiQCell stem cell therapy »

At Regeneus, we focus on improving quality of life through cellular therapies.

We develop and commercialise proprietary technologies for the preparation of autologous point-of-care and off-the-shelf cell therapies for the treatment of musculoskeletal and other inflammatory conditions in humans and animals.

More about Regeneus »

Our Therapies

Human Health

HiQCell is an innovative autologous stem cell therapy for musculoskeletal conditions such as osteoarthritis and tendinopathy.

Animal Health

CryoShot is an off-the-shelf stem cell therapy used for the treatment of conditions such as osteoarthritis in dogs and horses.